In this episode, Drs. Joseph Marine and Rajeev Pathak dive into the ARREST-AF trial and its implications for ablation outcomes in atrial fibrillation (AFib) patients. Listen as they explore the key findings of the trial, including the best approaches to risk factor management for AFib, and why catheter ablation remains a critical treatment option. Learn about the patient population in the ARREST-AF trial, along with the primary and secondary outcomes.
Drs. Marine and Pathak break down the key clinical takeaways and valuable insights on optimizing AFib management and improving outcomes through evidence-based strategies.
Subscribe on Apple Podcasts | Subscribe to ACCEL
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research